Skip to main content
Menu
News
Resources
Careers
Autoimmune Life Blog
Contact
Search form
Search
What is BRI
About BRI
Immune System Diseases
Scientists & Laboratories
Research at BRI
Join Our Research
Track Our Clinical Research
Type 1 Diabetes Research
Centers of Discovery
Programs
Recent Publications
Collaborations
For Scientists
Programs
Core Labs
Principal Scientist Labs
Scientific Staff
Publications
For Industry
Contact Us
Business Development Team
Available Technologies
Industry Collaborations
Clinical Research Program -- for Sponsors
Support BRI
BRI Fundraising Events
Become a Champion
Ways to Give
Donate
You are here
Home
/
Research at BRI
/
Track Our Clinical Research
/
Currently Enrolling Studies
/
Cancer
Track Our Clinical Research
HIV/AIDS Malignancies
Contact:
CancerResearch@VirginiaMason.org
or (206) 287-6270
Clinical Studies
Diagnosis
Relapsed/Refractory
De Novo
AMC 088: for High-grade Anal Squamous Intraepithelial Lesions
AMC 095: Nivolumab/Ipilimumab in solid tumors
✔
AMC 096: sEphB4-HSA in Treating Patients With Kaposi Sarcoma
AMC 098: Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
AMC-101
(AIDS-related Lymphomas)
Tissue Acquisition for Analysis of Prognostic Factors, Immunology, and Genetic Progression of HIV-1 Associated Malignancies
ANCHOR Study: Anal Cancer/HSIL Outcomes Research Study
Research at BRI
Join Our Research
Track Our Clinical Research
Why Participate in Clinical Research?
Currently Enrolling Studies
Allergies & Asthma
Anesthesiology
Cancer
Cardiology
Diabetes
Gastroenterology
Gynecology
Liver Disease
Neurological Diseases
Rheumatic Diseases
Surgery
Urology
Clinical Research Program - for Sponsors
Type 1 Diabetes Research
Centers of Discovery
Programs
Recent Publications
Collaborations
